In vivo dynamics of type 1 fimbria regulation in uropathogenic Escherichia coli during experimental urinary tract infection

Infection and Immunity

Volumn 69, Issue 5, 2001, Pages 2838-2846

  Gunther IV, N W ^a   Lockatell, V ^a   Johnson, D E ^a   Mobley, H L T ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PYELONEPHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATION; BLADDER; CONTROLLED STUDY; CYSTITIS; DISEASE SEVERITY; EPITHELIUM CELL; ESCHERICHIA COLI; FIMBRIA; GENETIC TRANSCRIPTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SCANNING ELECTRON MICROSCOPY; URINALYSIS; URINARY TRACT INFECTION;

ANIMALS; BACTERIAL ADHESION; CYSTITIS; ESCHERICHIA COLI; FIMBRIAE, BACTERIAL; MICE; MICE, INBRED CBA; MICROSCOPY, ELECTRON, SCANNING; PYELONEPHRITIS; URINARY TRACT INFECTIONS;

EID: 0035059034     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.5.2838-2846.2001     Document Type: Article

References (40)

1. An invertible element of DNA controls phase variation of type 1 fimbriae of Escherichia coli
2. Molecular epidemiology of adhesin and hemolysin virulence factors among uropathogenic Escherichia coli
3. Lrp stimulates phase variation of type 1 fimbriation in Escherichia coli K-12
4. Integration host factor stimulates both
5. Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract
6. Integration host factor is required for the DNA inversion that controls phase variation in Escherichia coli
7. Environmental regulation of the fim switch controlling type 1 fimbrial phase variation in Escherichia coli K-12: Effects of temperature and media
8. Interaction of FimB and FimE with the fim switch that controls the phase variation of type 1 fimbriae in Escherichia coli K-12
9. The leucine-responsive regulatory protein binds to the fim switch to control phase variation of type 1 fimbrial expression in Escherichia coli K-12
10. Development of experimental model of chronic pyelonephritis with Escherichia coli O75:K5:H-bearing Dr fimbriae: Mutation in the dra region prevented tubulointerstitial nephritis
11. Genomic analysis of a pathogenicity island in uropathogenic Escherichia coli CFT073: Distribution of homologous sequences among isolates from patients with pyelonephritis, cystitis, and catheter-associated bacteriuria and from fecal samples
12. Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin
13. The nationwide nosocomial infection rate. A new need for vital statistics
14. Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli
15. Characteristics of Escherichia coli in acute community-acquired cystitis of adult women
16. Community-acquired pyelonephritis in adults: Characteristics or E. coli isolates in bacteremic and non-bacteremic patients
17. Comparison of Escherichia coli strains recovered from human cystitis and pyelonephritis infections in transurethrally challenged mice
18. Pathogenicity island sequences of pyelonephritogenic Escherichia coli CFT073 are associated with virulent uropathogenic strains
19. Rapid site-specific DNA inversion in Escherichia coli mutants lacking the histonelike protein H-NS
20. Receptor-binding function of type 1 pili effects bladder colonization by a clinical isolate of Escherichia coli
21. In vivo expression and variation of Escherichia coli type 1 and P pili in the urine of adults with acute urinary tract infections
22. Two regulatory fim genes, fimB and fimE, control the phase variation of type 1 fimbriae in Escherichia coli
23. Direct evidence that the FimH protein is the mannose-specific adhesin of Escherichia coli type 1 fimbriae
24. Urinary tract infections in females
25. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination
26. Regulation of type 1 fimbrial expression in uropathogenic Escherichia coli: Heterogeneity of expression through sequence changes in the fim switch region
27. In vivo phase variation of Escherichia coli type 1 fimbrial genes in women with urinary tract infection
28. Roles of fimB and fimE in site-specific DNA inversion associated with phase variation of type 1 fimbriae in Escherichia coli
29. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli
30. Localization of promoters in the fim gene cluster and the effect of H- NS on the transcription of fimB and fimE
31. The Pai-associated leuX specific tRNA5(Leu) affects type 1 fimbriation in pathogenic Escherichia coli by control of FimB recombinase expression
32. Virulence of Escherichia coli in relation to host factors in women with symptomatic urinary tract infection
33. Relationship of type 1 pilus expression in Escherichia coli to ascending urinary tract infections in mice
34. Pathogenic adaptation of Escherichia coli by natural variation of the FimH adhesin
35. Bacterial adhesins: Common themes and variations in architecture and assembly
36. Urovirulence determinants in Escherichia coli isolates causing first-episode and recurrent cystitis in women
37. Type 1 fimbriation and phase switching in a natural Escherichia coli fimB null strain, Nissle 1917
38. Clinical presentation and epidemiology of urinary tract infections
39. A randomized, controlled trial of cefoperazone vs. cefamandole-tobramycin in the treatment of putative, severe infections with gram-negative bacilli
40. Regulatory cross-talk between adhesin operons in Escherichia coli: Inhibition of type 1 fimbriae expression by the PapB protein